Allspring Global Investments’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$783K Buy
72,739
+7,292
+11% +$65.2K ﹤0.01% 1251
2025
Q4
$535K Buy
65,447
+5,704
+10% +$40.7K ﹤0.01% 1354
2025
Q3
$318K Sell
59,743
-588
-1% -$2.24K ﹤0.01% 1466
2025
Q2
$212K Sell
60,331
-3,275
-5% -$9.74K ﹤0.01% 1539
2025
Q1
$157K Buy
63,606
+22,307
+54% +$87.4K ﹤0.01% 1672
2024
Q4
$170K Buy
41,299
+96
+0.2% +$522 ﹤0.01% 1688
2024
Q3
$292K Buy
41,203
+2,547
+7% +$19K ﹤0.01% 1604
2024
Q2
$252K Buy
38,656
+29,087
+304% +$199K ﹤0.01% 1661
2024
Q1
$79.4K Buy
+9,569
New +$93.3K ﹤0.01% 1883
2023
Q1
Sell
-1,113
Closed -$16.6K 2914
2022
Q4
$16.6K Sell
1,113
-25
-2% -$479 ﹤0.01% 2624
2022
Q3
$25K Hold
1,138
﹤0.01% 2571
2022
Q2
$19K Sell
1,138
-19,746
-95% -$423K ﹤0.01% 2500
2022
Q1
$625K Buy
20,884
+1,896
+10% +$46K ﹤0.01% 2127
2021
Q4
$583K Buy
+18,988
New +$600K ﹤0.01% 2233

Other funds holding RLAY